series-a
Stage
2
Investors
About
Capnia develops the CoSense® ETCOc Monitor, a non-invasive medical device that measures end-tidal carbon monoxide in newborns' breath to detect and monitor hemolysis, enabling improved management of neonatal jaundice and reducing the risk of bilirubin neurotoxicity.
Explore Capnia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.